Idarubicin Terminated Phase 2 Trials for Leukemias Treatment

IndicationsStatusPurposePhase
TerminatedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00003729Combination Chemotherapy in Treating Children With Relapsed or Refractory Acute Lymphocytic Leukemia
NCT00528450Tretinoin and Arsenic Trioxide With or Without Idarubicin in Treating Patients With Acute Promyelocytic Leukemia